Erik Jensen

EDX Medical Group Plc engages in the provision of medical goods in the United Kingdom. It distributes Guardant Health’s cancer genomic tests for healthcare providers in Sweden, Denmark, Norway, Finland and Iceland (Nordics), also serving the private healthcare sector in the United Kingdom. The company was founded by Christopher Thomas Evans and Michael Hudson John on March 19, 2021 and is headquartered in Cambridge, the United Kingdom.

EDX Medical Group Plc engages in the provision of medical goods in the United Kingdom. It distributes Guardant Health’s cancer genomic tests for healthcare providers in Sweden, Denmark, Norway, Finland and Iceland (Nordics), also serving the private healthcare sector in the United Kingdom. The company was founded by Christopher Thomas Evans and Michael Hudson John on March 19, 2021 and is headquartered in Cambridge, the United Kingdom.

EDX Medical Group Plc engages in the provision of medical goods in the United Kingdom. It distributes Guardant Health’s cancer genomic tests for healthcare providers in Sweden, Denmark, Norway, Finland and Iceland (Nordics), also serving the private healthcare sector in the United Kingdom. The company was founded by Christopher Thomas Evans and Michael Hudson John on March 19, 2021 and is headquartered in Cambridge, the United Kingdom.

EDX Medical Group Plc engages in the provision of medical goods in the United Kingdom. It distributes Guardant Health’s cancer genomic tests for healthcare providers in Sweden, Denmark, Norway, Finland and Iceland (Nordics), also serving the private healthcare sector in the United Kingdom. The company was founded by Christopher Thomas Evans and Michael Hudson John on March 19, 2021 and is headquartered in Cambridge, the United Kingdom.